Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Radiation in Newly Diagnosed Glioblastoma
NCT00165477Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Sep 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in glioblastoma (GBM), Gliosarcoma (GS), sponsored by Dana-Farber Cancer Institute. Started Sep 2005; status: completed.
02
Drugs
lenalidomide
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00165477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165477.